Let's Win
  • About
    • Our Mission & Story
    • Scientific Advisory Board
    • Advisory Committee
    • Founders
    • Sponsors & Partners
    • Our Team
  • My Treatment
  • Managing Pancreatic Cancer
  • Innovative Science
    • Promising Science
    • Clinical Trials
  • News
    • Newsfeed
    • In the News
  • Resources
    • Resource Library
    • Pancreatic Cancer Connections
    • Symptoms
    • Stages
    • Videos
    • What is Standard of Care?
    • Glossary
  • Donate

PARP inhibitors

Molecular Profiling: Getting To Know Your Tumor

Molecular Profiling: Getting to Know Your Tumor

Dr. Johanna Bendell explains the value of molecular profiling. It can indicate which type of chemotherapy will be more successful on your tumor.

BRCA’s Role In Pancreatic Cancer Investigated

BRCA’s Role in Pancreatic Cancer Investigated

The relationship between BRCA and pancreatic cancer, and how that affects treatment, is the focus of clinical trials looking at PARP inhibitors.

Exploring The Effectiveness Of An Experimental Class Of Drug

Exploring the Effectiveness of an Experimental Class of Drug

Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?

The Impact Of BRCA Is Broader Than Breast And Ovarian Cancer

The Impact of BRCA is Broader Than Breast and Ovarian Cancer

Rona Greenberg discusses the impact of BRCA2 on her family, and her search for the best clinical trial for her needs after her pancreatic cancer diagnosis.

Tags
5-FU Abraxane BRCA1 BRCA2 breast cancer CA 19-9 cancer chemotherapy Cisplatin clinical trial Clinical Trials drug combinations Clinical Trials immunotherapy Clinical Trials radiation Clinical Trials Stage of Disease: Metastatic or Advanced CT Scan DNA fluorouracil FOLFIRINOX Gemcitabine Gemzar genetic testing Immunotherapy Irinotecan Leucovorin Lustgarten metastatic My Treatment chemotherapy radiation My Treatment clinical trials My Treatment genomic testing My Treatment pancreatectomy surgery My Treatment Whipple procedure oncologist Oxaliplatin pancreas pancreatic cancer phase II Promising Science clinical trials Promising Science genetic familial mutations radiation SBRT stage IV stereotactic body radiation therapy surgery tumor Xeloda

About

Our Mission & Story Scientific Advisory Board Advisory Committee Founders Sponsors & Partners Our Team

Resources

Resource Library Pancreatic Cancer Connections Symptoms Stages Videos What is Standard of Care? Glossary

Stories

My Treatment Promising Science Clinical Trials Managing Pancreatic Cancer Newsfeed In the News All Stories

Contact Us

Donate

Connect

Twitter Icon In Medium Purple
Facebook Icon In Medium Purple
Ig

About

Our Mission & Story Scientific Advisory Board Advisory Committee Founders Sponsors & Partners Our Team

Resources

Resource Library Pancreatic Cancer Connections Symptoms Stages Videos What is Standard of Care? Glossary

Stories

My Treatment Promising Science Clinical Trials Managing Pancreatic Cancer Newsfeed In the News All Stories

Contact Us

Donate

Connect

Twitter Icon In Medium Purple
Facebook Icon In Medium Purple
Ig
Twitter Icon In Medium Purple
Facebook Icon In Medium Purple
Ig

Join our community Sign up for updates from Let’s Win!

Terms & Conditions • Privacy Policy

Please note that this information is not intended to be a substitute for professional medical opinion, advice or diagnosis. We encourage you to use this information to begin a dialogue with your physician about the treatment plan that is right for you.

©2018 | Let’sWin! An online community for sharing information about innovative, science-based treatments for Pancreatic Cancer.